CD4 and colitis: In addition, GC-treated murine bone marrow monocytes also inhibited anti-CD3/CD28-induced proliferation of CD4+ and CD8+ T-cells in vitro and inhibited CD4+ T-cell-induced colitis in a therapeutic setting (134).